LONDON DAILY ARCHIVE
Infected Blood Victims Express Distress Over Compensation Scheme
Victims of the infected-blood scandal voice concerns as inquiry chairman prepares further report.
14 March 2025 · 03:42 UTC
This sentiment comes as Sir Brian Langstaff, the chairman of the Infected Blood Inquiry, announces plans to publish a report addressing the timeliness and adequacy of the government’s response to the treatment disaster.
The inquiry recently released new witness statements that capture the emotional toll on the community, describing distress and a sense of being unheard.
Sir Brian noted that these expressions of distress "can neither be denied nor ignored." Since the inquiry's final report was published in May 2022, the government announced a compensation scheme the following day.
In the October Budget, Chancellor Rachel Reeves allocated £11.8 billion for compensation, which is to be administered by the Infected Blood Compensation Authority (IBCA).
However, concerns regarding the implementation and timeline of the compensation have arisen, with campaigners indicating that victims feel overlooked.
Witnesses have reported a lack of communication and expressed fears that the government is attempting to “silence” community voices to mitigate embarrassment regarding delays in compensation.
One testimonial conveyed that anxiety levels among affected individuals are reaching unprecedented heights, resulting in severe emotional distress.
Additionally, allegations surfaced about the Cabinet Office allegedly obstructing financial progress and arguing against the necessity of independent legal representation for affected individuals.
Following the publication of the inquiry report and the announcement of the compensation scheme, organizations like the Haemophilia Society have reported a surge in contact from distressed individuals seeking guidance.
The charity criticized the timing of the compensation announcement, emphasizing the absence of centralized support for applicants.
Sir Brian Langstaff acknowledged the expressed distress, affirming the inquiry's objective to identify practical measures to alleviate community concerns.
He expressed a commitment to ensure that the process does not contribute to further delays in providing compensation to victims.
The inquiry is expected to make additional statements next month and will assess whether further hearings are necessary, alongside outlining the timeline for written submissions.
In a recently revealed statistic, a lawyer representing victims remarked that only about 0.2% of eligible claimants have been invited to seek payouts under the current compensation scheme.
This lawyer, Des Collins, noted that the scheme is not equipped to manage the volume of applications it should be processing.
Collins welcomed the upcoming further report from the inquiry, highlighting the urgent need for transparency regarding the implementation of the compensation scheme, which has so far seemed opaque to many concerned parties.
Kate Burt, chief executive of the Haemophilia Society, emphasized the critical nature of the inquiry's role in ensuring that the government adheres to its recommendations and helps address the fear and despair permeating the affected community.
A government spokesperson acknowledged the severity of the victims' suffering, reaffirming their commitment to cooperate with the inquiry and act on its recommendations.
To date, the government has allocated £11.8 billion for compensation, made offers exceeding £48 million, and disbursed £1 billion in interim payments.